Banner
Home → Focus

Focus
Federal Judge in Texas Overturns ACA Print E-mail
Written by FHI's Week in Review   
Monday, 17 December 2018 00:00
 
Late in the day Friday, Dec. 14, 2018 multiple media outlets reported the shocking news. Peter Sullivan reports for The Hill:
A federal judge in Texas on Friday struck down the Affordable Care Act, throwing a new round of uncertainty into the fate of the law just one day before the deadline to sign up for coverage for next year. U.S. District Court Judge Reed O'Connor ruled that the law's individual mandate is unconstitutional, and that because the mandate cannot be separated from the rest of the law, the rest of the law is also invalid...The reasoning of the ruling states that in 2012, the Supreme Court upheld the mandate to have coverage because of Congress's power to tax. But, last year, Congress removed the fine for failing to comply with the mandate, which, he <O'Connor> argues, means the mandate is no longer a tax and therefore is unconstitutional.
Read more in the current issue of Week in Review>> https://conta.cc/2Evy17m
 
Last Updated on Friday, 25 January 2019 17:25
 
Fentanyl is the deadliest drug in America, CDC confirms Print E-mail
Written by Nadia Kounang, CNN   
Thursday, 13 December 2018 00:00
 
Fentanyl is now the most commonly used drug involved in drug overdoses, according to a new government report. The latest numbers from the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics say that the rate of drug overdoses involving the synthetic opioid skyrocketed by about 113% each year from 2013 through 2016. The number of total drug overdoses jumped 54% each year between 2011 and 2016. In 2016, there were 63,632 drug overdose deaths. According to Wednesday's report, which analyzed death certificates for drug overdose deaths between 2011 and 2016, fentanyl was involved in nearly 29% of all overdose deaths in 2016. In 2011, fentanyl was involved in just 4% of all drug fatalities.
 

Last Updated on Friday, 14 December 2018 17:58
 
Investigation of generic 'cartel' expands to 300 drugs Print E-mail
Written by FHInews   
Tuesday, 11 December 2018 19:01
 
Chistopher Rowland reports, for the Washington Post on 12.9.18, about a case involving the generic pharmaceutical industry that is rapidly gaining steam. Investigators are looking into executives at more than a dozen generic-drug  companies over a massive price-fixing scheme, in what is being called potentially the largest U.S. drug cartel. The investigation reportedly began in 2016, in response to a complaint filed by states against two drugs. The ring of pharmaceutical companies has allegedly overcharged consumers and taxpayers for common drugs ranging from antibiotics to anxiety pills to asthma medication, authorities said. The effects have rippled throughout the health care sector, also affecting hospitals and insurance companies.

Read the Washington Post story HERE.
(Warning: Paywall may apply.)

Fox News does a nice summary of the WaPo article HERE.
(No paywall.)

Last Updated on Tuesday, 11 December 2018 19:05
 
AHA, AAMC sue Trump administration over site-neutral payment rule Print E-mail
Written by Tina Reed | Fierce Healthcare   
Wednesday, 05 December 2018 00:00
 
Two of the nation's largest healthcare groups are suing the Trump administration over a final rule to institute site-neutral payments for clinic visits, saying the policy would hurt patients. Last month, the Centers for Medicare & Medicaid Services (CMS) finalized the 2019 Outpatient Prospective Payment System (OPPS) rule, which will gradually institute site-neutral payments in the Medicare program over the next two years. Agency officials said site-neutral payments for clinic visits will lower out-of-pocket costs for beneficiaries and save the program as much as $380 million in 2019. In a complaint filed in the U.S. District Court for the District of Columbia, the American Hospital Association (AHA) and the Association of American Medical Colleges (AAMC) said the rule would lead to access problems as hospitals cut services, hurting vulnerable patients. The associations claimed the administration is overstepping its legal bounds and were joined in the legal action by Olympic Medical Center in Port Angeles, Washington; Mercy Health in Muskegon, Michigan; and York Hospital in York, Maine.
 

Last Updated on Friday, 07 December 2018 18:44
 
The scientist, the twins and the experiment that geneticists say went too far Print E-mail
Written by FHI's Week in Review   
Monday, 03 December 2018 15:53
 
Helen Regan, Rebecca Wright and Alexandra Field report for CNN on Dec. 1, 2018:  
 
Chinese scientist He Jiankui announced to the world that he successfully used the gene-editing tool CRISPR-Cas9 to modify the DNA of two embryos before birth, essentially creating the world's first genetically modified humans...Editing the DNA of human embryos that go on to deliver has never been done before. And with good reason, scientists say. The technology is still in its infancy and could lead to a multitude of unknown genetic complications later in life. Scientists have reached an understanding that implanting such an embryo is a boundary that shouldn't be crossed until the risks are reduced or eliminated.
 
Read more in the current issue of Week in Review>> https://conta.cc/2RBNeHO
 
Last Updated on Friday, 18 January 2019 18:03
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 9 of 137


Banner
Website design, development, and hosting provided by
Netphiles